HC2

Cards (136)

  • Multiple Sclerosis
    • Idiopathic
    • Demyelination of neurons, resulting in disruption of axon function
  • Theories of Multiple Sclerosis
    • Autoimmune
    • Environmental factors with genetic predisposition
  • Multiple Sclerosis
    • Vitamin D deficiency
    • More common in women
    • More common if Caucasians
    • Genetics
  • Autoimmune processes in Multiple Sclerosis
    Leave scars known as sclerosis, plaques or lesions
  • Multiple Sclerosis
    Impedes transmission of impulses to and from the brain/spinal cord
  • Multiple Sclerosis can occur anywhere in CNS where there is white matter (myelinated nerve cells)
  • Types of Multiple Sclerosis
    • Relapsing-remitting
    • Primary Progressive
    • Secondary Progressive
    • Progressive relapsing
  • Relapsing-remitting Multiple Sclerosis
    Exacerbations and remissions in 85-90% of patients
  • Primary Progressive Multiple Sclerosis
    10% of patients, no distinct periods of remission from onset
  • Secondary Progressive Multiple Sclerosis
    40-50% of people with relapsing-remitting develop this form within 10 years of dx, starts out as r-r then gradually develops into a progressive pattern
  • Progressive relapsing Multiple Sclerosis
    5% of patients, progressive from onset with acute exacerbations, superimposed on the progressive
  • Diagnosing Multiple Sclerosis
    1. History
    2. Physical and neurological exam
    3. Evidence of demyelination in at least 2 areas of CNS, occurring at 2 different time
    4. Rule out other conditions
  • Tests used to diagnose Multiple Sclerosis
    • MRI
    • Evoked potentials tests
    • Lumbar puncture
    • Optical coherence tomography
  • Symptoms of Multiple Sclerosis
    • Fatigue
    • Visual disturbance
    • Sensory impairments
    • Motor impairments
    • Loss of postural control
    • Dizziness
    • Tremor
    • Dysphagia
    • Speech disturbances
    • Heat intolerance
    • Spasticity
    • Bowel and bladder dysfunction
  • Management of Multiple Sclerosis
    • Medications (anti-depressants, antispasmodics, corticosteroids)
    • Catheterization
    • Tube feeding
    • Nerve blocks
  • Uthoff's phenomenon
    Worsening of neurological function in MS patients in response to increases in core body temperature
  • Parkinson's
    • Idiopathic
    • Degeneration of neurons that produce dopamine in an area of the Basal Ganglia called the Substantia Nigra
  • Theories of Parkinson's
    • Accelerated aging
    • Environmental toxins
    • Free radical oxidative damage
  • Parkinson's
    • More common in males
    • History of depression
  • Symptoms of Parkinson's
    • Tremors
    • Rigidity
    • Bradykinesia
  • Diagnosing Parkinson's
    1. History and physical examination
    2. Hoehn and Yahr Rating Scale (5 stages, 1 = unilateral involvement, mild symptoms, tremor to stage 5= wasting stage, bed ridden, unable to walk, severe swallowing problems)
  • Primary symptoms of Parkinson's (TRAP)
    • Tremors (present when awake or at rest)
    • Rigidity (resistance to movement, festinating gait)
    • Akinesia or Bradykinesia (no movement or slow movement)
    • Postural instability (impaired balance)
  • Festinating gait in Parkinson's
    Short, shuffled steps, forward tilt of trunk, reduced arm swing, rigid head, will increase in speed, losing control
  • Other symptoms of Parkinson's
    • Loss of coordination
    • Micrographia
    • Lack of facial expression
    • Drooling
    • Dysphagia
    • Dementia
    • Sleep problems
    • Loss of bladder and bowel control
    • Depression
    • Muscle cramps
    • Pain
    • Fatigue
    • Skin problems
  • Management of Parkinson's
    • Medications (dopamine agonists-converts into dopamine, anticholinergic drugs- reduce tremor)
    • Surgical (deep brain stimulation- will only reduce symptoms)
  • Parkinson's
    • High fall risk
    • 'Freezing' behaviour
    • Possible dysphagia
    • Increased risk for pressure ulcers
  • Coronary Artery Disease
    • Atherosclerosis
    • Angina and myocardial infarction are results of CAD
  • Coronary Artery Disease can affect coronary arteries, myocardium, conduction system, pericardium and valves
  • Coronary Artery Disease is the 2nd leading cause of death in Canada
  • Atherosclerosis
    Caused by elevated levels of Low Density Lipid concentration in the bloodstream the "bad" cholesterol
  • Myocardial Infarction
    Can be caused by a narrowing from plaque formation or a thrombus which forms when plaque ruptures and the artery attempts to heal itself but the clot blocks off the artery
  • Tissue damage can spread for up to 6 weeks after an MI if heart works too hard
  • Risk factors for Coronary Artery Disease
    • Heredity
    • More common for males
    • Age
    • Diabetes
    • High blood pressure
    • Smoking
    • Stress
    • Obesity
  • Listen to the warning signs (chest pain)
  • Tests for Coronary Artery Disease
    • Angiography
    • Blood and urine tests
    • Cardiac cath
    • Echocardiogram
    • Electrocardiogram
    • Stress test
  • Angina
    Aching pain in central chest, may spread to left arm or jaw
  • Other symptoms of Coronary Artery Disease
    • Fatigue
    • SOB
    • Cough
    • Psychological symptoms
  • Psychosocial effects of Coronary Artery Disease
    • Fear and anxiety
    • Feeling helpless
    • Feeling of loss of control over health
    • Denial
    • Depression
  • Management of Coronary Artery Disease
    • Anticoagulants and anti-platelet agents
    • ACE inhibitors
    • Vasodilators
    • Beta blockers
  • Cardiac Rehabilitation
    • Improve cardiac condition
    • Physical conditioning
    • Reduce cardiac distress symptoms
    • Improve overall health
    • Prevent cardiac problems